Overview
ANG Lifesciences India Limited specializes in manufacturing and marketing sterile dry powder injection vials, primarily targeting hospitals and doctors through stockists.
The company operates four formulation plants in Baddi, Himachal Pradesh, equipped with advanced technology for producing Beta Lactum and Non-Beta Lactum products.
ANG Lifesciences has expanded its geographical presence into India, Africa, Gulf countries, and ROW countries, reflecting a growing international footprint.
The acquisition of Mansa Printers & Publishers Limited in April 2021 marks a strategic move for cost optimization in pharma packaging through backward integration.
Compliance with GMP requirements and ISO 9001:2008 certification underscores the company's commitment to quality and operational excellence.
- Sector
Pharmaceuticals & Biotechnology
- Industry
Pharmaceuticals
- Market Cap
40 Cr
- Volatility
Low Risk
- P/E Ratio
0.0
- Industry P/E
34.1
- PEG Ratio
—
- P/B Ratio
0.8
- 52W High
39.70
- 52W Low
17.63
Financial Ratios
Sales CAGR
- 1Y
- -36.45%
- 3Y
- -36.35%
- 5Y
- -6.65%
- 10Y
- 5.63%
Profit CAGR
- 1Y
- -22.39%
- 3Y
- —
- 5Y
- —
- 10Y
- —
ROE
- TTM
- -20.96%
- 3Y
- -8.57%
- 5Y
- 7.71%
- 10Y
- 10.42%
ROCE
- TTM
- -3.83%
- 3Y
- 2.57%
- 5Y
- 18.28%
- 10Y
- 20.36%
Technicals
Oscillators
Bearish
Bearish
6
Neutral
2
Bullish
6
Overall
Bullish
Bearish
6
Neutral
2
Bullish
38
Moving Averages
Bullish
Bearish
0
Neutral
0
Bullish
32
Actions
AI Mode
Get instant AI-powered insights about company performance, financials, and strategy. Ask questions about trends, competition, and developments while receiving responses backed by official documents and market data, with clear attribution to source documents.
Ask AI
